1. Prostaglandin A2 blocks the activation of G1 phase cyclin-dependent kinase without altering mitogen-activated protein kinase stimulation. Hitomi M, Shu J, Strom D, Hiebert SW, Harter ML, Stacey DW (1996) J Biol Chem 271(16): 9376-83
    › Primary publication · 8621603 (PubMed)
  2. CCAAT enhancer-binding protein (C/EBP) and AML1 (CBF alpha2) synergistically activate the macrophage colony-stimulating factor receptor promoter. Zhang DE, Hetherington CJ, Meyers S, Rhoades KL, Larson CJ, Chen HM, Hiebert SW, Tenen DG (1996) Mol Cell Biol 16(3): 1231-40
    › Primary publication · 8622667 (PubMed) · PMC231105 (PubMed Central)
  3. An AML-1 consensus sequence binds an osteoblast-specific complex and transcriptionally activates the osteocalcin gene. Banerjee C, Hiebert SW, Stein JL, Lian JB, Stein GS (1996) Proc Natl Acad Sci U S A 93(10): 4968-73
    › Primary publication · 8643513 (PubMed) · PMC39389 (PubMed Central)
  4. AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia. Meyers S, Lenny N, Sun W, Hiebert SW (1996) Oncogene 13(2): 303-12
    › Primary publication · 8710369 (PubMed)
  5. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Okuda T, van Deursen J, Hiebert SW, Grosveld G, Downing JR (1996) Cell 84(2): 321-30
    › Primary publication · 8565077 (PubMed)
  6. The tissue-specific nuclear matrix protein, NMP-2, is a member of the AML/CBF/PEBP2/runt domain transcription factor family: interactions with the osteocalcin gene promoter. Merriman HL, van Wijnen AJ, Hiebert S, Bidwell JP, Fey E, Lian J, Stein J, Stein GS (1995) Biochemistry 34(40): 13125-32
    › Primary publication · 7548073 (PubMed)
  7. The t(8;21) fusion protein interferes with AML-1B-dependent transcriptional activation. Meyers S, Lenny N, Hiebert SW (1995) Mol Cell Biol 15(4): 1974-82
    › Primary publication · 7891692 (PubMed) · PMC230424 (PubMed Central)
  8. The AML1/ETO fusion protein blocks transactivation of the GM-CSF promoter by AML1B. Frank R, Zhang J, Uchida H, Meyers S, Hiebert SW, Nimer SD (1995) Oncogene 11(12): 2667-74
    › Primary publication · 8545124 (PubMed)
  9. Indirect and direct disruption of transcriptional regulation in cancer: E2F and AML-1. Meyers S, Hiebert SW (1995) Crit Rev Eukaryot Gene Expr 5(3-4): 365-83
    › Primary publication · 8834231 (PubMed)
  10. Heterogeneity in CBF beta/MYH11 fusion messages encoded by the inv(16)(p13q22) and the t(16;16)(p13;q22) in acute myelogenous leukemia. Shurtleff SA, Meyers S, Hiebert SW, Raimondi SC, Head DR, Willman CL, Wolman S, Slovak ML, Carroll AJ, Behm F (1995) Blood 85(12): 3695-703
    › Primary publication · 7780153 (PubMed)